Many of the variants in BMP signaling components (e.g., SMAD6, BMP2, BMP7) increase the risk of craniosynostosis rather than causing craniosynostosis directly, suggesting that interactions between pathways (namely, BMP and FGF) may contribute to the etiology of this disorder. Here, SMAD6 is linked to craniosynostosis.